• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床局限性前列腺癌中10号和17号染色体杂合性缺失

Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.

作者信息

Ittmann M M

机构信息

Department of Pathology, New York University School of Medicine, Kaplan Comprehensive Cancer Center, New York, USA.

出版信息

Prostate. 1996 May;28(5):275-81. doi: 10.1002/(SICI)1097-0045(199605)28:5<275::AID-PROS1>3.0.CO;2-B.

DOI:10.1002/(SICI)1097-0045(199605)28:5<275::AID-PROS1>3.0.CO;2-B
PMID:8610052
Abstract

Loss of heterozygosity (LOH) at chromosomal loci has been associated with the presence of tumor suppressor genes at the deleted loci. Twenty-six clinically localized, Stage B prostate carcinomas were analyzed for LOH on chromosomes 10 and 17 using microsatellite markers. Two of 26 carcinomas showed LOH on 17p while one showed LOH on 17q. Chromosome 10 showed a complex pattern of LOH with monosomy (1 case), LOH on 10p (1 case), proximal 10q (1 case) and distal 10q (2 cases). Overall 29% of informative cases showed LOH on chromosome 10. These results are consistent with the presence of a tumor suppressor for prostate cancer on 17p and multiple tumor suppressor genes on chromosome 10.

摘要

染色体位点的杂合性缺失(LOH)与缺失位点处肿瘤抑制基因的存在有关。使用微卫星标记对26例临床局限性B期前列腺癌进行了10号和17号染色体上LOH的分析。26例癌中有2例在17p显示LOH,1例在17q显示LOH。10号染色体显示出复杂的LOH模式,包括单体型(1例)、10p上的LOH(1例)、10q近端(1例)和10q远端(2例)。总体而言,29%的信息性病例在10号染色体上显示LOH。这些结果与17p上存在前列腺癌肿瘤抑制基因以及10号染色体上存在多个肿瘤抑制基因一致。

相似文献

1
Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.临床局限性前列腺癌中10号和17号染色体杂合性缺失
Prostate. 1996 May;28(5):275-81. doi: 10.1002/(SICI)1097-0045(199605)28:5<275::AID-PROS1>3.0.CO;2-B.
2
Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.前列腺腺癌中16号染色体长臂杂合性缺失:三个独立区域的鉴定。
Cancer Res. 1997 Mar 15;57(6):1058-62.
3
Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.晚期前列腺癌中7q31.1和12p13 - 12区域的杂合性缺失
Prostate. 2002 Sep 15;53(1):60-4. doi: 10.1002/pros.10131.
4
Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.人类前列腺癌中BRCA1及17号染色体长臂上其他基因座的杂合性缺失
Cancer Res. 1995 Mar 1;55(5):1002-5.
5
P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer.8号染色体、16号染色体、17号染色体和18号染色体上的P53突变及杂合性缺失仅限于晚期前列腺癌。
Anticancer Res. 1994 Nov-Dec;14(6B):2785-90.
6
Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.脑膜瘤:肿瘤进展过程中10号染色体杂合性缺失分析以及与其他癌症共有的四个染色体缺失区域的划定
Clin Cancer Res. 2003 Oct 1;9(12):4435-42.
7
Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.在人类前列腺癌中,将潜在肿瘤抑制基因座定位到17号染色体长臂上一个小于2兆碱基的区域。
Oncogene. 1995 Oct 5;11(7):1241-7.
8
Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.在乳腺微切割顶泌汗腺癌中,在染色体1p35 - 36(神经母细胞瘤)、3p25(VHL)、16p13(TSC2/PKD1)和17p13(TP53)检测到杂合性缺失。
Mod Pathol. 1999 Dec;12(12):1083-9.
9
Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.唾液腺肿瘤杂合性全面缺失分析及3p21处新热点的鉴定。
Otolaryngol Head Neck Surg. 2007 Jul;137(1):119-25. doi: 10.1016/j.otohns.2007.01.017.
10
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.原发性前列腺癌中PTEN/MMAC1频繁失活。
Cancer Res. 1997 Nov 15;57(22):4997-5000.

引用本文的文献

1
Toward Systems Pathology for PTEN Diagnostics.迈向 PTEN 诊断的系统病理学。
Cold Spring Harb Perspect Med. 2020 May 1;10(5):a037127. doi: 10.1101/cshperspect.a037127.
2
Leucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef/Tcf-dependent transcription through Akt/GSK3β signaling pathway in lung cancer.亮氨酸拉链肿瘤抑制因子 2 通过 Akt/GSK3β 信号通路抑制肺癌细胞增殖并调节 Lef/Tcf 依赖性转录。
J Histochem Cytochem. 2013 Sep;61(9):659-70. doi: 10.1369/0022155413495875. Epub 2013 Jun 12.
3
Genetics of prostate cancer.
前列腺癌的遗传学
Clin Med Res. 2003 Jan;1(1):21-8. doi: 10.3121/cmr.1.1.21.
4
Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma.人血影蛋白src同源结构域结合蛋白1表达缺失与人类前列腺腺癌10号染色体短臂缺失相关。
Neoplasia. 2001 Mar-Apr;3(2):99-104. doi: 10.1038/sj.neo.7900145.
5
Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis).前列腺非典型腺瘤样增生(腺病)的基因分析。
Am J Pathol. 1999 Sep;155(3):967-71. doi: 10.1016/S0002-9440(10)65196-6.
6
Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.BRCA1和BRCA2基因的常见突变与犹太男性早期前列腺癌无关。
Prostate. 1999 Aug 1;40(3):172-7. doi: 10.1002/(sici)1097-0045(19990801)40:3<172::aid-pros5>3.0.co;2-r.
7
Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers.原发性乳腺癌中PTEN/MMAC1基因的罕见突变。
Jpn J Cancer Res. 1998 Jan;89(1):17-21. doi: 10.1111/j.1349-7006.1998.tb00473.x.